Dishman Carbogen Amcis Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹851.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.28 per cent from ₹719.80 crore. This corresponds to a year-on-year *(YoY) growth of 18.85 per cent.
Operating Profit
Operating Profit stands at ₹161.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 43.05 per cent from ₹113.11 crore. This corresponds to a year-on-year *(YoY) growth of 14.80 per cent.
PBDT
PBDT stands at ₹134.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.37 per cent from ₹73.98 crore. This corresponds to a year-on-year *(YoY) growth of 26.34 per cent.
Profit Before Tax
Profit Before Tax stands at ₹46.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 541.86 per cent from ₹-10.44 crore. This corresponds to a year-on-year *(YoY) growth of 66.53 per cent.
Net Profit
Net Profit stands at ₹21.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 267.62 per cent from ₹-12.97 crore. This represents a 49.55 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Dishman Carbogen Amcis Ltd Earnings
- YOY
- QOQ
Dishman Carbogen Amcis Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dishman Carbogen Amcis Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Dishman Carbogen Amcis Ltd Financial Reports
Dishman Carbogen Amcis Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dishman Carbogen | 0.29% | 2.73% | -11.96% | 18.83% | -31.22% | -31.04% |
| Panacea Biotec | -3.91% | -2.69% | 26.68% | 68.80% | 43.11% | 28.85% |
| Unichem Labs. | 2.90% | 9.47% | 29.61% | 58.60% | 6.84% | -19.31% |
| Kwality Pharma | -3.44% | 11.29% | 17.91% | 89.93% | 144.82% | 133.53% |
| Sai Parenteral's | 4.45% | 4.89% | 22.65% | 51.37% | 51.37% | 51.37% |
| Solara Active | -2.10% | -0.17% | 4.39% | 19.49% | -2.58% | -12.26% |
| Hikal | -1.08% | 1.93% | 14.01% | 36.19% | -3.61% | -36.78% |
Company Info
Company Information
WTD & Executive Director : Deohooti J Vyas
ED / Global MD / Promoter : Arpit J Vyas
Independent Non Exe. Director : KULIN NALINKANT SHAH
Independent Non Exe. Director : Hemantkumar J Bhatt
Independent Non Exe. Director : Margie S Parikh
Non-Exec & Non-Independent Dir : Dhaval R. Shah
Company Sec. & Compli. Officer : Shrima Dave